Chicago Says Drug Cos. Shouldn't Exit Opioid Bellwether Suit
By Lauraann Wood · June 23, 2020, 6:47 PM EDT
Johnson & Johnson and Teva Pharmaceuticals can't escape a Chicago bellwether case over their allegedly deceptive opioid marketing because earlier rulings have already largely upheld the allegations, the city argued Monday....
To view the full article, register now.